FDA approves Zejula for the maintenance treatment of women with recurrent ovarian cancer March 28, 2017
FDA approves Symproic for opioid-induced constipation in adults with chronic non-cancer pain March 24, 2017
Truxima becomes the first biosimilar MAb in oncology to be granted E.U. marketing authorization Feb. 23, 2017
RSS